Drug-Related Side Effects and Adverse Reactions: all 449 studies

Page 3 of 5. Open to participants first (77), then studies with results posted, then the rest; newest registration first within each.

• The Influence of CYP2C19 Polymorphisms on the Safety and Efficacy of VoriconazoleStatus unknownNCT04547335
• Post-marketing Safety Surveillance of Qizhi Tongluo Capsules:a Registry Study.Status unknownNCT04479553
• Assessment of Mortality Rates in COVID-19 Infected Populations Treated With Repurposed MedicationsWithdrawnNCT04432350
• Cardiovascular Complications of CarfilzomibStatus unknownNCT04407858
• A Randomized Open-labeled Study for Comparing Methods of Using Imrecoxib to Treat ASStatus unknownNCT04400786Not applicable
• Simulation of Risk of Adverse Drug Events Associated With the Initiation of Drugs Repurposed for the Treatment of COVID-19 in Adults With Polypharmacy Using Data From Large Medicare and Commercially Insured PopulationsStatus unknownNCT04378881
• Comparison of MAPI+Camrelizumab Versus API+Apatinib Versus MAPI in Patients With a Poor Response to Preoperative Chemotherapy for Newly Diagnosed High-grade OsteosarcomaStatus unknownNCT04351308Phase 2
• Over-the-counter (OTC) Labels for Older AdultsCompletedNCT04345731Not applicable
• Simulation of Risk of Adverse Drug Events Associated With the Initiation of Drugs Repurposed for the Treatment of COVID-19 in Frail Elderly Adults With PolypharmacyCompletedNCT04339634
• Infliximab for Treatment of Immune Checkpoint Inhibitor ColitisActive, not recruitingNCT04305145Phase 2
• Chimeric Antigen Receptor T-cell and Cellular Therapies for the Treatment of cAncer or BLood Diseases: Evaluation of Reporting of Adverse EventsCompletedNCT04279470
• Efficacy and Safety of AD-MSCs Plus Calpocitriol Ointment and PSORI-CM01 Granule in Psoriasis PatientsCompletedNCT04275024Not applicable
• Apatinib for Inoperable Advanced ChondrosarcomaCompletedNCT04260113Not applicable
• Effects of Switching From Racemic Methadone to R-methadone on QTc IntervalsActive, not recruitingNCT04254731Phase 4
• The Knowledge, Attitudes and Practices of Healthcare Workers on Drug Hypersensitivity Reactions in ChildrenCompletedNCT04252326Not applicable
• DOAC ADRs Retrospective StudyTerminatedNCT04247919
• Malnutrition in Older Adults: An Intervention Based on Medication Review and Individual Nutritional PlanStatus unknownNCT04228900Not applicable
• The Use of Midazolam and Remifentanil During Dialysis Access ProceduresCompletedNCT04226443Not applicable
• Taste of Medicines in ChildrenCompletedNCT04220918
• Reducing Errors In The Neonatal Intensive Care UnitStatus unknownNCT04193839
• Effectiveness of an ADE-related Hospitalization Risk Prediction Tool for Patients (ADE-RED)CompletedNCT04181775
• Ivermectin Neurotoxicity and ABCB1 Gene MutationsCompletedNCT04174469
• Selinexor as Single Agent and With Imatinib in Metastatic and/or Unresectable Gastrointestinal Stromal Tumors (SeliGIST)Active, not recruitingNCT04138381Phase 1/2
• MedSafer E-care: an Automated Deprescribing Solution (E-CARE Study)WithdrawnNCT04087109Not applicable
• Improving Medication Prescribing-Related Outcomes for Vulnerable Elderly in TransitionsCompletedNCT04077281Not applicable
• Plasma Concentrations of Amoxicillin Administered in High-doses During the First Week of Treatment (MAX-AMOX)CompletedNCT04070469Phase 4
• Impact of Pharmacists' Training on Oral Anticoagulant CounselingCompletedNCT03999905Not applicable
• Monitoring the Antiphospholipid Syndrome:TOXicity of Drugs (APSTOX)CompletedNCT03994302
• Evaluation of the Neurological and Psychiatric Adverse Events of Dolutegravir and Bictegravir in Real LifeWithdrawnNCT03964584
• Incidence of Iatrogenic Diseases on Hospital's Emergency ConsultationsCompletedNCT03960398
• Monitoring the Hyperammonaemia:TOXicity of Drugs (AmmoTOX)CompletedNCT03947034
• Drug Interactions in Outpatients.SuspendedNCT03943524Not applicable
• Evaluation of a Drug Interactions Software to Limit PolypharmacyCompletedNCT03901820Not applicable
• Association Between Genetic Variant Scores and Warfarin EffectCompletedNCT03894878
• Combination of Methotrexate(MTX) and Actinomycin(ACTD) in the Low Risk Gestational Trophoblastic Neoplasma （GTN） Patients With Score of 5-6Status unknownNCT03885388Phase 2/3
• Could Music be an Alternative to Sedation in Patients Treated Total Knee Arthroplasty With Regional Anesthesia?CompletedNCT03882541Not applicable
• Improving Wisely - PolypharmacyCompletedNCT03857100Not applicable
• Best Possible Medication History at USBCompletedNCT03851328
• Pharmacogenetics Study on the Effects of Anesthetic Drugs on Circulatory FunctionCompletedNCT03839186
• Evaluation of MyoStrain™ in Clinical PracticeCompletedNCT03825224
• Denosumab Related Osteonecrossi of the Jaw : : an Emergent and Potentially Complex Bone and Joint InfectionCompletedNCT03808285
• Reducing High-Risk Geriatric Polypharmacy Via EHR Nudges: Pilot PhaseWithdrawnNCT03791580Not applicable
• Schistosomiasis Diagnosis Using a CAA Antigen TestStatus unknownNCT03779347Phase 3
• Pharmacist and Data Driven Quality Improvement in Primary CareCompletedNCT03747107
• Efficacy and Safety of Expanded UCMSCs On Patients With Moderate to Severe PsoriasisStatus unknownNCT03745417Phase 1/2
• Impact of an Optimized Communication on the Readmission for Adverse Drug EventCompletedNCT03725046Not applicable
• A Pharamcogenomic Study for Isoniazid According to NAT2 Polymorphism StatusCompletedNCT03665402Not applicable
• GHB Poisoning and Poisoning Induced by OthersCompletedNCT03651778
• Post-marketing Safety Surveillance of Xueshuantong-Injection : a Registry StudyStatus unknownNCT03640884
• Efficacy and Adverse Effects of Prapchompoothaweep Remedy and Loratadine for Treatment in AR PatientsCompletedNCT03640273Phase 2
• Subconjunctival Atropine and Intracameral Epinephrine for Pupil Dilation in PhacoemulsificationStatus unknownNCT03638726Phase 4
• TIL and Anti-PD1 in Metastatic MelanomaActive, not recruitingNCT03638375Phase 1/2
• Evaluation of Efficacy and Safety of Subcutaneous AcetaminophenCompletedNCT03635684Phase 2
• Outcomes in Stevens Johnsons Syndrome and Toxic Epidermal NecrolysisWithdrawnNCT03585946
• A Study to Evaluate the Benefit of RUCONEST® in Subjects Who Experience ADRs Related to IVIG InfusionsCompletedNCT03576469Phase 4
• Partnering With Patients for Improving Medication Safety During Transitions of Care: Implications for Work System DesignWithdrawnNCT03544034Not applicable
• Therapeutic Drug Monitoring for Individualized Clozapine TherapyStatus unknownNCT03523741
• Discontinuation of Long-term Medications in Older People Entering Nursing Home CareStatus unknownNCT03501108Not applicable
• Voluntary Drug Poisoning by Psychoactive Molecules: Identify Cognitive MarkersStatus unknownNCT03481192Not applicable
• Impact of AferBio® on Quality of Life and Chemotherapy Toxicity in Lung Cancer PatientsStatus unknownNCT03469063Not applicable
• Adverse Drug Events at Emergency DepartmentCompletedNCT03442010
• Impact of Pharmacotherapeutic Education on Medication Adherence and Adverse Outcomes in Type 2 DiabetesCompletedNCT03438162Not applicable
• The Pharmacist in the Acute Geriatric Inpatient Treatment TeamCompletedNCT03412903
• Gerontology Research Programme: The Singapore Longitudinal Ageing Studies (SLAS I & II)Status unknownNCT03405675
• Efficacy and Safety of AD-MSCs Plus Calpocitriol Ointment in Patients With Moderate to Severe PsoriasisCompletedNCT03392311Phase 1/2
• Deprescribing of Symptomatic Medications in Rehabilitative or Subacute Care PatientsStatus unknownNCT03354845Not applicable
• Effect and Associated Factors of the Clinical Pharmacy Model in the Incidence of Medical ErrorsCompletedNCT03338725Not applicable
• Adverse Drug Reactions in Pediatrics: Experience of a Regional Pharmacovigilance CenterCompletedNCT03316014
• Adverse Drug Reactions to Anti-TB Drugs in the Treatment of Latent Tuberculosis InfectionStatus unknownNCT03312647
• Adherence and Coagulation Assays in Dabigatran-treated Patients With Atrial FibrillationCompletedNCT03280368
• Reducing Post-discharge Adverse Drug Events Amongst the Elderly: a Multi-centre Electronic Deprescribing InterventionCompletedNCT03272607Not applicable
• Motion Sickness Medications and Vestibular Time ConstantCompletedNCT03270839Phase 4
• Safety and Efficacy of Expanded Allogeneic AD-MSCs in Patients With Moderate to Severe PsoriasisCompletedNCT03265613Phase 1/2
• Association of Genetic Polymorphisms With Docetaxel-based Chemotherapy Toxicities in Chinese Solid Tumor PatientsStatus unknownNCT03258151
• Association of Genetic Polymorphisms With Capecitabine-based Chemotherapy Toxicities in Chinese Solid Tumor PatientsStatus unknownNCT03258099
• PIPAC for Peritoneal Metastases of Colorectal CancerCompletedNCT03246321Phase 2
• Neuropsychiatric Side Effects of Efavirenz in Children Living With HIVCompletedNCT03227653
• Effects of Repeated Doses of Lu AF35700 on Drug Metabolizing EnzymesCompletedNCT03195946Phase 1
• Different Chemotherapy Protocols Combined With Intensity Modulated Radiation Therapy in Patients With Locally Advanced Nasopharyngeal CarcinomaCompletedNCT03177174Not applicable
• Drug Patch Tests in Patients With Severe Cutaneous Adverse Reaction to Drugs (SCARs)Status unknownNCT03176342Not applicable
• Impact of Clinical Pharmacist on Adverse Drug Events in Older AdultsStatus unknownNCT03156348Not applicable
• Bupivacaine Levels in Liver Resection PatientsCompletedNCT03145805
• Pain Medication After Ambulatory SurgeryTerminatedNCT03135470
• Side Effects of Anti-PD-(L)-1 and Anti CTLA-A4 in the Non Small Cells Lung CancerCompletedNCT03125603
• Improving Drug Safety in Emergency Patients -a Randomized Controlled TrialCompletedNCT03123640Not applicable
• Safety and Tolerability of Krill Powder Supplement in Slightly Overweight People With Moderately Elevated Blood PressureCompletedNCT03112083Not applicable
• A Study of the Pharmacokinetic and Pharmacodynamic Responses in Healthy and Altered Human Cardiovascular SystemsTerminatedNCT03098680Phase 1
• PREemptive Pharmacogenomic Testing for Preventing Adverse Drug REactionsCompletedNCT03093818Not applicable
• Phase 2 Trial to Evaluate 18-Methoxycoronaridine Efficacy, Safety and Tolerability in Cutaneous Leishmaniasis PatientsStatus unknownNCT03084952Phase 2
• Study of Orally-Administered AMXT 1501 Dicaprate in Normal Healthy VolunteersWithdrawnNCT03077477Phase 1
• Preventive Effect of EGF Cream for Cutaneous Adverse Event of EGFR InhibitorsStatus unknownNCT03051880Not applicable
• Therapeutic Effect of EGF Cream for Cutaneous Adverse Event of EGFR InhibitorsStatus unknownNCT03047863Not applicable
• SAPhIRE Statin Adverse Drug ReactionStatus unknownNCT03042286
• NATIENS: Optimal Management and Mechanisms of SJS/TENCompletedNCT02987257Phase 3
• Patient Safety Learning Laboratory: Making Acute Care More Patient-CenteredCompletedNCT02969343Not applicable
• Switching From Tenofovir Disoproxil Fumarate to Abacavir or Tenofovir AlafenamideStatus unknownNCT02957864Phase 4
• Comparison of Adverse Drug Reactions Associated for Oxycodone and Morphine in Postoperative Pain After Abdominal HysterectomyStatus unknownNCT02936934Phase 4
• Medication Reconciliation Using Electronic Pharmaceutical Record: A Multicenter Study in the Hospitalized ElderlyCompletedNCT02906657Not applicable
• Serious Adverse Drug Reaction and Their PreventabilityCompletedNCT02888834
• Does IVPCA Increase Opioid Consumption and Side Effects in Fast Track Orthopedic Procedures?Status unknownNCT02880800Not applicable

← Drug-Related Side Effects and Adverse Reactions overview